Chemoinformaics analysis of 1-O-vanilloyl-beta-D-glucose
| Molecular Weight | 330.289 | nRot | 4 |
| Heavy Atom Molecular Weight | 312.145 | nRig | 13 |
| Exact Molecular Weight | 330.095 | nRing | 2 |
| Solubility: LogS | -1.443 | nHRing | 1 |
| Solubility: LogP | -0.642 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 42.6003 |
| nHD | 5 | BPOL | 24.1337 |
| QED | 0.41 |
| Synth | 3.425 |
| Natural Product Likeliness | 1.813 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.214 |
| HIA | 0.903 |
| CACO-2 | -5.959 |
| MDCK | 0.000248735 |
| BBB | 0.806 |
| PPB | 0.32957 |
| VDSS | 0.45 |
| FU | 0.541515 |
| CYP1A2-inh | 0.04 |
| CYP1A2-sub | 0.07 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.109 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.477 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.224 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.02 |
| CL | 4.886 |
| T12 | 0.84 |
| hERG | 0.019 |
| Ames | 0.211 |
| ROA | 0.014 |
| SkinSen | 0.025 |
| Carcinogencity | 0.043 |
| EI | 0.014 |
| Respiratory | 0.018 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.591589 |